be important to determine if the large, medium and small CR-ip neurons have different connectivity and thus segregate function. Interestingly our results regarding the decreased density of CR-ip interneurons are in line with our previous observations in ASD 1 Background: Genome-wide association studies demonstrated that multiple genetic variants are associated with schizophrenia (SCZ). Additional evidence revealed that genes are prone to operate in functional molecular networks that subtend complex clinical phenotypes. This knowledge raises the need to investigate how genes linked to SCZ and their possible co-regulators are inserted into molecular networks with a key impact in disease pathogenesis. Using post-mortem brain mRNA data sets (Pergola et al. 2017), we have previously identified a co-expression network enriched for SCZ risk genes, including DRD2, the gene coding for the D2 dopamine receptor, and predicted cognitive and neuroimaging phenotypes of SCZ, as well as response to antipsychotic treatment. Given the relevance of DRD2 to the pathophysiology of SCZ, in the current study we sought to further our understanding of biological mechanisms underpinning co-expression of the DRD2 network. In detail, we aimed at probing the hypothesis that expression of genes within the DRD2-related co-expression network is modulated by a common transcriptional regulation involving one or more Transcription factors (TFs). Methods: In order to identify TF binding sites (TFBSs) in the promoter region of the 85 genes belonging to the DRD2 co-expression network, we performed a motif enrichment analysis using Pscan and Genomatix MatInspector tools. Biological validation experiments were performed in primary mouse cortical neurons. By real-time PCR analysis we measured the mRNA transcript levels of a group of genes included in the DRD2 co-expression module in basal conditions and upon viral vector-mediated overexpression (OE) and knockdown (KD) of the predicted TFs. We studied expression of genes linked to either DRD2 in the co-expression gene set, such as Gpld1, Chit1, Btg4 and Osr1, or SCZ risk, such as Gatad2a and Slc28a1. We also analyzed transcript levels of Cnr1, which mediates cannabinoid-induced transmission and is relevant to SCZ. Moreover, we analyzed the transcript levels of D2 long splicing isoform (D2L), which was included in the co-expression network, and D2 short splicing isoform (D2S), to verify whether TF regulation was specific for D2L. Results: Promoters of the DRD2 co-expression gene set were enriched for two TFBSs, recognized by Nur-Related Factor 1 (NURR1, FDR-adjusted p=0.03) and Estrogen-Related Receptor Alpha (ERR1, FDR-adjusted p=0.02), respectively. Validation experiments in mouse primary cortical neurons established that NURR1, and not ERR1, is a regulator of genes of the DRD2 co-expression module analyzed in this study. In detail, Nurr1 gain of function (OE) decreased Cnr1 transcript levels (p=0.0002),
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T198. A SCHIZOPHRENIA-LIKE BIRTH SEASONALITY AMONG MATHEMATICIANS AND AN OPPOSITE SEASONALITY AMONG BIOLOGISTS: MORE EVIDENCE IMPLICATING BIMODAL RHYTHMS OF GENERAL BIRTHS
Giovanni Marzullo* ,1
Per Aspera Research Foundation
Background: Based on early-20th century births, a pre-electric illumination time of comparatively normal human exposure to sunlight, studies of schizophrenia (SCZ) found a birth seasonality with two opposite effects: a SCZ-liability peak among subjects born around late-February and an equally significant SCZ-resistance peak among those born six months later, around late-August. We previously investigated this rhythm in connection with a sunlight-dependent bimodal rhythm of general births that, prior to the full advent of electric lighting (but not later), occurred ubiquitously in non-equatorial parts of the world. We found that the SCZliability peak coincided with a first, Feb-Mar peak of general-population births (the GP1) while the SCZ-resistance peak coincided with a second, Aug-Sep peak of those births (the GP2). Moreover, in a study of hand and visual-field preferences among professional baseball players, we found the SCZ-liability, GP1-coincident seasonality among players with preferences denoting cerebral asymmetry "deficits" (CADs) and the SCZ-resistance, GP2-coincident seasonality among those with preferences denoting cerebral asymmetry "excesses." Also, in a study suggested by associations of CADs with artistic abilities, we found the SCZ-liability, GP1-coincident seasonality among groups representing visual, performing and literary art "creators" (VPL-Artists) and the SCZ-resistance, GP2-coincident seasonality among groups representing art critics, historians, curators and other art "observers" (Para-Artists). Together, these findings suggested, as one possibility (but see later), that the SCZ-liability, CAD effects and artistic abilities could all three represent traits genetically or otherwise selected into the GP1 excess population of newborns and out of the GP2 population. The present study of "scientists" was initially aimed at the purported arts/ science antithesis. Methods: Birth seasonalities were examined among early-20th century born American scientists and among yet earlier European biologists and mathematicians. Results: A group representing 1,925 American scientists showed the SCZresistance, GP2-coincident seasonality. However, this effect proved to be mostly due to biologists because biochemists, chemists, and physicists showed gradually less seasonality while mathematicians suggested an altogether artist-like, GP1-coincident seasonality. This intimation of a biologist-mathematician antithesis was pursued with an investigation of most major figures in the history of the two sciences from the 15th to the early-20th century. The two groups, numbering 576 mathematicians and 787 biologists, shared the same mean decade of birth, the 1780s, and essentially the same geographic origin in Western Europe. The mathematicians showed a very significant SCZ liability-like, GP1-coincident seasonality while the biologists showed an even more significant SCZ resistance-like, GP2-coincident seasonality. The latter effect was particularly strong among naturalists, anatomists and other groups representing biological "observationalism" as opposed to "experimentalism." Discussion: The findings are discussed in light of a) new evidence that the annual photoperiod is indeed alone responsible for both peaks of general births, with the GP1 and the GP2 being caused by maternal periconceptional exposure to, respectively, the summer-solstice sunlight maximum and the winter-solstice minimum, and b) an approach/withdrawal theory of lateralization of basic emotions where the left cerebral cortex would handle external stimuli eliciting complacent emotions towards external realities while the right cortex would handle internal stimuli eliciting disdain for those realities.
T199. DEVIANT CORTICAL SULCATION RELATED TO SCHIZOPHRENIA, BUT NOT COGNITIVE DEFICITS, LIKELY PREDATE BRAIN DEVELOPMENT IN THE SECOND TRIMESTER
Lena Palaniyappan* ,1
University of Western Ontario
Background: Gestational disruptions are linked to the risk of schizophrenia; but in most cases, there is a lack of a clear history or observable anomaly indicating that the disruptions are likely to be subtle (Murray et al., 2017) . The time-locked development of cortical sulci in a human embryo is highly sensitive to developmental disruptions (Chi et al., 1977) . We can retrospectively infer the likely timing of embryonic/fetal disruption in schizophrenia by studying the structure of major cortical sulci that represent lobar development in adults with schizophrenia. Methods: Anatomical T1 MRI scans from a publicly available dataset (COBRE) of 68 patients with schizophrenia and 72 controls were used to evaluate the sulcal depth. 5 major primary sulci that are invariable, representing lobar development (calcarine sulcus, superior temporal sulcus, superior frontal sulcus, interparietal sulcus and inferior frontal sulcus) with formation representing distinct developmental periods (16, 23, 25, 26 and 28 weeks respectively (Chi et al., 1977) ) were chosen. Sulcal depth was measured using Morphologist interface of BrainVISA 4.5 (http://brainvisa.info/). Following the construction of 3-dimensional models of cortical folds, various sulci were automatically classified using a probabilistic algorithm with maximum depth computed for each identified sulcus. The 5 sulci were consistently labeled automatically across all subjects. The identified sulci were visually inspected to ensure that the boundaries are in accordance with Ono's Atlas of Cerebral Sulci (Ono et al., 1990) . Results: A repeated measure ANOVA with 5 sulci and 2 hemispheres as within-subject factors and gender, age and intracranial volume as covariates revealed a significant between-subjects effect for diagnosis (F[1,134]=14.8, p=0.0002). Gender (F[1,134]=7.4, p=0.007) and age (F[1,134]=4.5, p=0.035) also had significant effect in the model. Parameter estimates revealed a significant effect of diagnosis (Controls>Patients) for left superior temporal (t=3.2, p=0.002), right superior temporal (t=2.8, p=0.006), right inferior frontal (t=2.7, p=0.007) and left calcarine (t=2.2, p=0.03) sulci. 5 non-collinear factors representing the 5 bilateral sulci were obtained using varimax rotation, and related to overall MATRICS standardized composite score in patients using multiple regression. The depth of the superior frontal sulcus was the only predictor of the variation in the cognitive score (F[1,54]=8.7, p=0.005). Discussion: The above findings suggest that the gestational cortical disruption underlying schizophrenia is likely to predate, if not, coincide with the appearance of calcarine sulcus (i.e. 16 weeks, early second trimester) and affects frontal, temporal and occipital lobes. Nevertheless, the burden of cognitive deficits may relate specifically to aberrant superior frontal development occurring in late second trimester. 
T200. DISTINCT ASSOCIATIONS OF MOTOR
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Background: Aberrant motor function is an integral part of Schizophrenia. In fact, abnormalities are frequently found in patients, in populations at risk, and in unaffected relatives. Motor abnormalities are suspected to be relevant for the clinical outcome and could probably predict the conversion from at-risk individuals to schizophrenia. Furthermore, motor function and has been argued as endophenotype of the disorder. Yet, which particular motor domain may classify as a potential endophenotype is unknown. We aimed to compare schizophrenia patients, unaffected first degree relatives and healthy controls for different motor domains. We expected impairments in all domains in patients and in some domains in relatives. Methods: We included 43 schizophrenia patients, 34 unaffected first degree relatives of schizophrenia patients and 29 healthy control subjects, matched for age, gender and education level. We compared motor function of five domains between the groups. The domains comprise neurological soft sings (NSS), abnormal involuntary movements (dyskinesia), Parkinsonism, complex fine motor function applying the coin rotation task as well as finger tapping. Furthermore, we tested the association of motor function of the five domains with working memory, frontal lobe function and nonverbal intelligence for each group separately using within-group bivariate correlations. Results: Schizophrenia patients showed poorer motor function in all tested domains compared to healthy controls. First-degree relatives had intermediate ratings with aberrant function in two motor domains. In detail, relatives had significantly more NSS and performed poorer in the finger tapping task than controls. In contrast, in relatives complex fine motor function was intact. Relatives did not differ from controls in dyskinesia or Parkinsonism severity. Discussion: Taken together, schizophrenia patients have motor abnormalities in all tested domains. Thus, motor abnormalities are a key element of the disorder. Likewise, first degree relatives presented motor deficits in two domains. A clear difference between relatives and healthy controls was found for NSS and finger tapping. Thus, NSS and finger tapping may be a potential marker of vulnerability for schizophrenia. The lack of association between genetic risk and dyskinesia or Parkinsonism suggests distinct pathobiological mechanisms in the various motor abnormalities in schizophrenia.
